ArticleFrontiers in pharmacology2022

Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD.

Yifan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.